Author:
Moriguchi S,Ishizuka T,Yabuki Y,Shioda N,Sasaki Y,Tagashira H,Yawo H,Yeh J Z,Sakagami H,Narahashi T,Fukunaga K
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology
Reference41 articles.
1. Greenamyre JT, Penney JB, D’Amato CJ, Young AB . Dementia of the Alzheimer’s type: changes in hippocampal L-[3H] glutamate binding. J Neurochem 1987; 48: 543–551.
2. Chen HS, Lipton SA . The chemical biology of clinically tolerated NMDA receptor antagonists. J Neurochem 2006; 97: 1611–1626.
3. Chen HS, Pellegrini JW, Aggarwai SK, Lei SZ, Warach S, Jensen F et al. Open-channel block of N-methyl-d-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 1992; 12: 4427–2236.
4. Lipton SA . Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer’s disease and other neurologic disorders. J Alzheimers Dis 2004; 6: S61–S74.
5. Fukunaga K, Stoppini L, Miyamoto E, Muller D . Long-term potentiation is associated with a increased activity of Ca2+/calmodulin-dependent protein kinase II. J Biol Chem 1993; 268: 7863–7867.
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献